爱博医疗: 688050爱博医疗 关于董事会换届选举的公告

Board Restructuring Announcement - The company is undergoing a board restructuring as the term of the second board is about to expire, in accordance with relevant laws and regulations [1][2] - The company will hold its annual general meeting in 2024 to vote on the new board members, with both non-independent and independent directors elected through a cumulative voting system [2][3] Board Candidates - The company has nominated several candidates for the third board, including non-independent directors: Xie Jiangbing, Wang Zhao, Jia Baoshan, Chen Yong, and Zhang Jian [1][2] - Independent director candidates include Wang Jing, Li Xunhu, and Wang Dongsheng, with Wang Jing being a professional accountant [1][2] Candidate Qualifications - All nominated candidates meet the qualifications required by laws and regulations, with no disqualifications under the Company Law or other relevant guidelines [2][4] - The candidates have no prior administrative penalties or disqualifications from the China Securities Regulatory Commission or stock exchanges [2][4] Current Board Performance - The current board has been diligent and has contributed positively to the company's sustainable development during their tenure [3]